Bullboard - Stock Discussion Forum Sonnet Biotherapeutics Holdings Inc SONN

Consumer Cyclical Biotechnology

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the... see more

Add To Watchlist

NDAQ:SONN - Post Discussion

Sonnet Biotherapeutics Holdings Inc > Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

View:

Post by whytestocks on Sep 25, 2024 5:47pm

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

NEWS: $SONN Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock SplitPRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it will effect a 1-for-8 reverse stoc...SONN - Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split